Simon Ducharme Selected Research

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

12/2023	Rationale and Design of the "DIagnostic and Prognostic Precision Algorithm for behavioral variant Frontotemporal Dementia" (DIPPA-FTD) Study: A Study Aiming to Distinguish Early Stage Sporadic FTD from Late-Onset Primary Psychiatric Disorders.
1/2022	Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon Ducharme Research Topics

Disease

29	Frontotemporal Dementia (Semantic Dementia) 04/2024 - 01/2018
9	Disease Progression 05/2024 - 12/2019
9	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 07/2013
7	Atrophy 01/2024 - 01/2018
5	Dementia (Dementias) 05/2024 - 07/2013
5	Mental Disorders (Mental Disorder) 03/2024 - 01/2019
3	Cognitive Dysfunction 05/2024 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2023 - 01/2022
2	Gliosis 01/2022 - 01/2020
2	Psychotic Disorders (Schizoaffective Disorder) 06/2019 - 01/2017
1	Prodromal Symptoms 01/2023
1	Sleep Apnea Syndromes (Sleep Apnea) 10/2022
1	Neuroinflammatory Diseases 09/2022
1	Tauopathies 01/2022
1	COVID-19 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Cerebral Cortical Thinning 01/2021
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2021
1	Kufor-Rakeb syndrome 06/2019
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Seizures (Absence Seizure) 01/2017
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2017
1	Epilepsy (Aura) 01/2017
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 07/2013
1	Opioid-Related Disorders (Opiate Addiction) 01/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2012

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2012
4	Tuberculin (PPD)IBA 03/2024 - 01/2019
4	ProgranulinsIBA 01/2023 - 01/2019
4	GranulinsIBA 01/2022 - 01/2021
3	Amyloid (Amyloid Fibrils)IBA 05/2024 - 07/2013
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2021
2	Indicators and Reagents (Reagents)IBA 05/2024 - 01/2024
2	TabletsIBA 01/2024 - 01/2023
2	Antisense OligonucleotidesIBA 10/2023 - 06/2023
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 08/2022
2	Complement System Proteins (Complement)IBA 09/2022 - 01/2020
2	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2020
2	neuronal pentraxinIBA 01/2022 - 01/2020
1	2- (3,4- dichlorophenyl)- N- methyl- N- (1- (3- isothiocyanatophenyl)- 2- (1- pyrrolidinyl)ethyl)acetamideIBA 12/2023
1	Blood Proteins (Serum Proteins)IBA 11/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	SuspensionsIBA 11/2021
1	Aripiprazole (Abilify)FDA Link 06/2019
1	Protons (Proton)IBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	Clozapine (Clozaril)FDA LinkGeneric 01/2017
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 07/2013
1	Naloxone Drug Combination Buprenorphine FDA Link 01/2012
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2012

Therapy/Procedure

2	Deep Brain Stimulation 01/2019 - 01/2011
1	Neurosurgical Procedures 01/2019